COVID-19-Associated Rhino-orbital mucormycosis: Presentation and outcome

Sanchita Saini; Satya P Singh; Vinod K Singh; Santosh Kumar; Sanskriti Singh; Shiv D Rajak

doi:10.4103/sjopt.sjopt_154_21

COVID-19-Associated Rhino-orbital mucormycosis: Presentation and outcome

Saudi J Ophthalmol. 2022 Aug 10;37(1):72-75. doi: 10.4103/sjopt.sjopt_154_21. eCollection 2023 Jan-Mar.

Authors

Sanchita Saini¹, Satya P Singh¹, Vinod K Singh¹, Santosh Kumar¹, Sanskriti Singh¹, Shiv D Rajak¹

Affiliation

¹ Department of Ophthalmology, Motilal Nehru Medical College, Medical College Campus, Prayagraj, Uttar Pradesh, India.

Abstract

We are reporting four accounts of rhino-orbital mucormycosis in patients during and after recovery from SARS-CoV-2 infection. The patients were diagnosed and treated for COVID-19 according to the current treatment protocols, following which they presented with sudden proptosis, ophthalmoplegia, and conjunctival injection, confirmed by magnetic resonance imaging and histopathological examination. The patients were treated with intravenous liposomal amphotericin B, and the outcome was observed. Early diagnosis and prompt intervention can substantially reduce the morbidity and mortality rates in these patients.

Keywords: Amphotericin B; COVID-19; fungal infection; mucormycosis.

Publication types

Case Reports